Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of a Protracted Temozolomide Schedule in Patients With Progression After Standard Dose Temozolomide for High-grade Gliomas

NCT00575887 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.

NCT NCT00575887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00575887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of a Protracted Temozolomide Schedule in Patients With Progression After Standard Dose Temozolomide for High-grade Gliomas
Lead sponsor
Marmara University
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2006
Completion date
March 31, 2009
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytoma, brain tumor, recurrent, glioblastoma, oligodendroglioma